TBC - Sign up for the latest updates
Berlin, GermanyKey Sessions
Gonzalo Fernández-Miranda
Enabling LNP-DNA Delivery to Target Peripheral Nerve Diseases
CureAge Therapeutics
Matthias Bozza
Targeted Lipid Nanoparticles Deliver Immune-Silent ssDNA to Generate CAR T Cells
CPTx
keyboard_arrow_right
Search keyboard_arrow_right
keyboard_arrow_left Hide
Thursday 5th November 2026 – Main Agenda - Day Two
search
Thursday 5th November 2026 – Main Agenda - Day Two
search
Showing 1 of 1 Streams
Registration Break
08:30 - 09:00
Registration & Morning Coffee
Showing 1 of 1 Streams
LNPs Europe
09:00 - 09:10
Welcome to LNPs Europe – Chairperson’s Welcome
09:10 - 09:40
Bridging Viral and Lipid Nanoparticle Worlds: Surface Engineering Lentiviral Vector-Based Nanoparticles for Targeted In Situ CAR-T Cell Therapy
- Céline Jaudoin - Senior Formulation Scientist, Alaya.bio
09:40 - 10:40
Panel Discussion: Scale-Up Strategies: Navigating the Road Ahead for In Vivo CAR-T
- Lorenz Mayr - Managing Director, BioMedTech Consulting GmbH
- Matthias Bozza - Director, Head of Strategy and R&D, CPTx
- Ulf Grawunder - Co-founder & CEO, T-CURX
Showing 2 of 2 Streams
Break
Poster Viewing - Meet the Poster Presenters
10:40 - 11:20
Morning Coffee and Networking Break in Exhibition Hall
10:40 - 11:20
Poster Viewing - Meet the Poster Presenters
Explore groundbreaking research, meet the poster presenters and ask your questions.
Showing 1 of 1 Streams
LNPs Europe
11:20 - 11:50
Enabling LNP-DNA Delivery to Target Peripheral Nerve Diseases
- Gonzalo Fernández-Miranda - CEO and Co-Founder, CureAge Therapeutics
11:50 - 12:20
Targeted Lipid Nanoparticles Deliver Immune-Silent ssDNA to Generate CAR T Cells
- Matthias Bozza - Director, Head of Strategy and R&D, CPTx
12:20 - 12:50
Sponsored Scientific Track Presentation: Designing Novel Chemistries and Novel Lipids to Overcome Bottlenecks - Endosomal Escape, Decrease Toxicity and Dosage Requirements
This session is your platform to demonstrate leadership and technical expertise. Present your data, case studies, and innovative solutions to a targeted audience of senior scientists and engineers looking to solve hurdles in their production processes.To learn more about sponsoring this session, contact us at Partners@informaconnectls.com
Showing 1 of 1 Streams
Break
12:50 - 14:00
Networking Lunch in the Exhibition Hall
Showing 1 of 1 Streams
LNPs Europe
14:00 - 14:30
R&D Innovations: Case Studies Next-Generation Therapeutic Applications of LNPs
- Katia Lemdani - Director Research and Development, Neovacs
14:30 - 15:00
Engineering LNPs for Next Generation Vaccines & Therapeutics
- Heinrich Haas - Chief Technology Officer, NeoVac
15:00 - 15:30
Refining LNP Design: Formulation Variables Influencing Biological Performance
- Aadarash Zia - Senior Scientist - Drug Delivery, Medicines Discovery Catapult
Showing 1 of 1 Streams
Break
15:30 - 16:00
Afternoon Coffee and Networking Break in Exhibition & Poster Hall
16:00 - 16:05
Close of Event 2026 – See You Next Year!